Gabriela Smit

CRS:

BJMC

Role:

Administrative and Finance

Position:

Senior Research Service Analyst

Email:

gsmit1@jhmi.edu

Ms. Smit is Fiscal Operations Manager at the Johns Hopkins Center for Clinical Global Health Education. She is an experienced financial analyst with more than 2 decades of experience in finance and accounting and more than a decade of experience at Johns Hopkins University, where she has developed and managed federal and non-federal grants and contracts.
 
While at the CCGHE, she has assembled and managed several international teams of investigators from a number of institutions, including JHU, BJGMC (Lakshya, India), UVRI (Rakai, Uganda), and the National Institute for Research in Tuberculosis (Chennai, India). Ms. Smit provided strategic financial and administrative input to support the new JHU entities in India (JHIPL and JHIF). She manages all financial activities within the US, India and is the key contact for JHU-India collaborations with the NIH Grant Office, the JHU Central Administration, and the JHU SOM Office of Research Administration and Business Office.  In October 2016, she received the Johns Hopkins Department of Medicine Staff Recognition Award for outstanding service. Ms. Smit received a Bachelor of Science degree in Finance and Accounting from Babes-Bolyai University of Cluj-Napoca, Romania

Categories

Leadership Committees
CRS
Roles

Clinical Trials

A5327: Sofosbuvir + Ribavirin w/o Interferon for Treatment...

A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...

Read More

Identification of Biomarkers That Can Predict Progression...

Purpose: The C-TRIUMPH study has identified 20 household contacts (HHC), who have progressed to active TB from its HHCs cohort...

Read More

A5349: Rifapentine-containing treatment shortening regimens...

The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...

Read More

IMPAACT 2034 - Phase I Study of the Pharmacokinetics,...

This is a Phase I, multi-site, open-label, non-comparative study of the PK, safety, tolerability, and acceptability of a...

Read More

A5274: REMEMBER, Reducing Early Mortality and Early...

This study is being done in people who are starting HIV treatment and who live in areas where the TB infection rate is high. The...

Read More